HI
BEAM icon

Harbour Investments’s Beam Therapeutics BEAM Stock Holding History

Harbour Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Buy
582
+419
+257% +$11.6K ﹤0.01% 3092
2025
Q4 		$4.52K Buy
+163
New +$4.16K ﹤0.01% 3051
2021
Q4 		$8K Sell
100
-50
-33% -$4.28K ﹤0.01% 1998
2021
Q3 		$13K Hold
150
– – ﹤0.01% 2515
2021
Q2 		$19K Buy
150
+102
+213% +$8.13K ﹤0.01% 2365
2021
Q1 		$4K Buy
+48
New +$4.57K ﹤0.01% 2964

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Harbour Investments's BEAM Position: Q1 2026 in Review

Harbour Investments increased its Beam Therapeutics (BEAM) stake by 257% in Q1 2026, buying an estimated $11.6K and bringing the position to 582 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Harbour Investments first reported a position in BEAM in Q1 2021 and has held it in 6 quarters since. The position peaked at $19K in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Harbour Investments held 582 shares of Beam Therapeutics worth $13.9K as of Q1 2026.
  • Harbour Investments bought 419 Beam Therapeutics shares in Q1 2026, an estimated $11.6K.
  • Beam Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #3092 holding.
  • Harbour Investments first reported a position in Beam Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • Harbour Investments's Beam Therapeutics position peaked at $19K in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.